- Home
- SGMT vs PHX Comparison
SGMT vs PHX Comparison
Compare SGMT & PHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- PHX
- Stock Information
- Founded
- SGMT 2006
- PHX 1926
- Country
- SGMT United States
- PHX United States
- Employees
- SGMT N/A
- PHX N/A
- Industry
- SGMT
- PHX Oil & Gas Production
- Sector
- SGMT
- PHX Energy
- Exchange
- SGMT Nasdaq
- PHX Nasdaq
- Market Cap
- SGMT 165.4M
- PHX 148.4M
- IPO Year
- SGMT 2023
- PHX N/A
- Fundamental
- Price
- SGMT $4.12
- PHX $4.14
- Analyst Decision
- SGMT Strong Buy
- PHX Buy
- Analyst Count
- SGMT 7
- PHX 1
- Target Price
- SGMT $25.71
- PHX $4.30
- AVG Volume (30 Days)
- SGMT 864.8K
- PHX 76.4K
- Earning Date
- SGMT 03-24-2025
- PHX 03-11-2025
- Dividend Yield
- SGMT N/A
- PHX 3.87%
- EPS Growth
- SGMT N/A
- PHX N/A
- EPS
- SGMT N/A
- PHX 0.13
- Revenue
- SGMT N/A
- PHX $31,939,771.00
- Revenue This Year
- SGMT N/A
- PHX N/A
- Revenue Next Year
- SGMT N/A
- PHX $28.73
- P/E Ratio
- SGMT N/A
- PHX $32.21
- Revenue Growth
- SGMT N/A
- PHX N/A
- 52 Week Low
- SGMT $2.39
- PHX $2.96
- 52 Week High
- SGMT $7.64
- PHX $4.24
- Technical
- Relative Strength Index (RSI)
- SGMT 43.11
- PHX 58.24
- Support Level
- SGMT $3.96
- PHX $4.00
- Resistance Level
- SGMT $4.83
- PHX $4.20
- Average True Range (ATR)
- SGMT 0.38
- PHX 0.13
- MACD
- SGMT -0.04
- PHX 0.02
- Stochastic Oscillator
- SGMT 13.39
- PHX 81.22
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.